- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/34 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 207/34
Total number of patents in this class: 574
10-year publication summary
|
37
|
27
|
25
|
27
|
31
|
41
|
25
|
32
|
21
|
20
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daiichi Sankyo Company, Limited | 1879 |
17 |
| Takeda Pharmaceutical Company Limited | 2719 |
16 |
| Sunshine Lake Pharma Co., Ltd. | 600 |
13 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 714 |
12 |
| Viatris Specialty LLC | 160 |
11 |
| Syngenta Crop Protection AG | 6229 |
9 |
| Activesite Pharmaceuticals, Inc. | 19 |
8 |
| Theravance Biopharma R&D IP, LLC | 453 |
8 |
| Syngenta Participations AG | 1745 |
6 |
| Bayer Cropscience SA | 34 |
6 |
| FUJIFILM Corporation | 29775 |
6 |
| Astellas Pharma Inc. | 1053 |
6 |
| Emory University | 1652 |
6 |
| Global Blood Therapeutics, Inc. | 183 |
6 |
| New York Blood Center, Inc. | 167 |
6 |
| VenatoRx Pharmaceuticals, Inc. | 84 |
6 |
| AstraZeneca AB | 2854 |
5 |
| Bayer Cropscience AG | 1996 |
5 |
| Ono Pharmaceutical Co., Ltd. | 427 |
5 |
| Tetraphase Pharmaceuticals, Inc. | 51 |
5 |
| Other owners | 412 |